March 18, 2020
Chugai Pharmaceutical on March 16 started a voluntary recall for its anticancer agent Herceptin for Intravenous Infusion 60 (trastuzumab) due to glass fragment contamination. No health hazard, so far, has been reported, according to the company. The glass contaminants were...read more